Previous slide
Next slide

NEWS COVERAGE

Our innovative IBD management system – Crohn’s Colitis Care (CCCare) – is revolutionising care and research.

Discover how our platform is expanding globally, partnering with top pharmaceutical companies to unlock a wealth of data, and democratising access to critical health information.

Click on the media articles to explore the latest news and advancements and stay tuned for more updates.

  1. Personalising IBD management with EMR data
    17 Sep 2024 – Access Here
  2. IBD app to bring help
    14 Sep 2024 – Access Here
  3. Consumer and clinician input needed for mobile, multi-disciplinary IBD app
    10 Sep 2024 – Access Here
  4. IBD global initiative
    05 Sep 2024 – Access Here
  5. Pharmacists have say in world-first solution to IBD problem
    05 Sep 2024 – Access Here
  6. Australian patients part of global push for personalised care solution
    05 Sep 2024 – Access Here
  7. Australian charity is leading a global coalition to develop a world-first solution to the escalating issue of Inflammatory Bowel Disease (IBD)
    04 Sep 2024 – Access Here
  8. Cloud-based IBD clinical management system going global
    02 Apr 2024 – Access Here
  9. From Australia to the world: democratising data to better understand IBD
    05 Mar 2024 – Access Here 
  10. Access to patient RWD up for grabs
    28 Feb 2024 – Access Here
  11. IBD care platform
    22 Feb 2024 – Access Here
  12. Access granted: Largest reservoir of IBD patient data unveiled with membership
    21 Feb 2024 – Access Here
  13. World-leading, ANZ-developed IBD patient data platform establishes its global value by partnering with ‘Top 5’ Pharma company
    20 Feb 2024 – Access Here
  14. Cloud based clinical platform brings relief for Inflammatory Bowel Disease (IBD) patients and practitioners
    12 Feb 2019 – Access Here

How you CAN help

CCCure receives no government funding, so your support is crucial in our mission to transform care for those with IBD.

Individuals can make a significant impact by donating to CCCure. Every contribution brings us closer to better research, care, treatments, and a cure, and helps make our world-first consumer app a reality. You can also help by sharing our mission and raising awareness about IBD, a condition often under-funded and under-recognised.

For organisations, including pharmaceutical companies and research institutions, you can support CCCure by subscribing to access our comprehensive data analytics. This partnership allows you to leverage our unique insights to drive innovation and improve outcomes in IBD care.

CCCure is an Australian-registered charity, and donations are tax deductible for Australian residents. Whether you're an individual or part of an organisation, join us in our journey to improve lives and find a cure for IBD.